Literature DB >> 30063295

Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.

Peter K Foote1, Alexander V Statsyuk1,2.   

Abstract

PARKIN is a RING-Between-RING (RBR) E3 ligase, which ubiquitinates mitochondrial proteins in response to mitochondrial damage. Ser65 of PARKIN is phosphorylated by kinase PINK1 (pPARKIN), which causes partial PARKIN activation. PINK1 also phosphorylates Ser65 of ubiquitin (pUb), which further activates pPARKIN. Due to the lack of precise and quantitative assays to quantify the activity of PARKIN, there were many conflicting reports on the role of pUb as a PARKIN activator, whether S65E PARKIN is a true phosphomimetic of pPARKIN, and the effect of substrate of PARKIN turnover was also not known. This protocol provides a step-by-step guide on the use of the UbFluor probe to precisely quantitate changes in the activity of PARKIN in response to phosphorylation, allosteric activation by pUb, protein substrates, and activating structural mutations. These results pave the way to discover PARKIN activators and to precisely quantify the activity of other RBR E3s.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  PARKIN; UbFluor; mitophagy; ubiquitin

Mesh:

Substances:

Year:  2018        PMID: 30063295      PMCID: PMC6125222          DOI: 10.1002/cpch.45

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  51 in total

1.  Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.

Authors:  Koji Yamano; Bruno B Queliconi; Fumika Koyano; Yasushi Saeki; Takatsugu Hirokawa; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

2.  Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro.

Authors:  Noriyuki Matsuda; Toshiaki Kitami; Toshiaki Suzuki; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

3.  Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Authors:  Masahiro Iguchi; Yuki Kujuro; Kei Okatsu; Fumika Koyano; Hidetaka Kosako; Mayumi Kimura; Norihiro Suzuki; Shinichiro Uchiyama; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

4.  Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism.

Authors:  Xinde Zheng; Tony Hunter
Journal:  Cell Res       Date:  2013-05-14       Impact factor: 25.617

Review 5.  Crosstalk between kinases and Nedd4 family ubiquitin ligases.

Authors:  Heeseon An; David T Krist; Alexander V Statsyuk
Journal:  Mol Biosyst       Date:  2014-01-24

6.  High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor.

Authors:  Peter K Foote; David T Krist; Alexander V Statsyuk
Journal:  Curr Protoc Chem Biol       Date:  2017-09-14

7.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

Authors:  Sathya R Sriram; Xiaojie Li; Han Seok Ko; Kenny K K Chung; Esther Wong; Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

8.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

9.  Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.

Authors:  Jing Lu; Yimin Qian; Martha Altieri; Hanqing Dong; Jing Wang; Kanak Raina; John Hines; James D Winkler; Andrew P Crew; Kevin Coleman; Craig M Crews
Journal:  Chem Biol       Date:  2015-06-04

10.  Pathogenic mutations inactivate parkin by distinct mechanisms.

Authors:  Iris H Henn; Johanna M Gostner; Peter Lackner; Jörg Tatzelt; Konstanze F Winklhofer
Journal:  J Neurochem       Date:  2005-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.